These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12107960)

  • 1. [Thioredoxin reductase--a new target for molecular medical investigations].
    Zagrodzki P
    Postepy Hig Med Dosw; 2002; 56(2):155-67. PubMed ID: 12107960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
    Zhao R; Masayasu H; Holmgren A
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A; Berggren M; Gasdaska JR; Powis G
    Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.
    Lee SR; Bar-Noy S; Kwon J; Levine RL; Stadtman TC; Rhee SG
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2521-6. PubMed ID: 10688911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
    Söderberg A; Sahaf B; Rosén A
    Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.
    Ren X; Zou L; Lu J; Holmgren A
    Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
    Lu J; Chew EH; Holmgren A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF; Di Trapani G
    Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
    Gorlatov SN; Stadtman TC
    Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction.
    Fang J; Zhong L; Zhao R; Holmgren A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):103-9. PubMed ID: 15979675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of Glu-469' in the acid-base catalysis of thioredoxin reductase from Drosophila melanogaster.
    Huang HH; Arscott LD; Ballou DP; Williams CH
    Biochemistry; 2008 Dec; 47(48):12769-76. PubMed ID: 18991392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional role of selenocysteine (Sec) in the catalysis mechanism of large thioredoxin reductases: proposition of a swapping catalytic triad including a Sec-His-Glu state.
    Brandt W; Wessjohann LA
    Chembiochem; 2005 Feb; 6(2):386-94. PubMed ID: 15651042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thioredoxin system in cancer.
    Arnér ES; Holmgren A
    Semin Cancer Biol; 2006 Dec; 16(6):420-6. PubMed ID: 17092741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
    Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
    Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.